Mouwasat Medical Services Company (TADAWUL:4002)

TADAWUL:4002 Ratios and Metrics

Market cap in millions SAR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 17, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	14,700	17,020	22,360	20,900	17,380	13,800
Market Cap Growth	-23.88%	-23.88%	6.99%	20.25%	25.94%	56.82%
Enterprise Value	15,095	17,693	23,174	21,901	18,178	14,533
Last Close Price	73.50	85.10	110.05	101.62	83.56	65.41
PE Ratio	22.76	26.36	34.00	34.87	30.06	26.13
Forward PE	19.58	20.61	30.17	29.27	26.82	25.70
PS Ratio	5.11	5.91	8.27	8.95	8.11	6.75
PB Ratio	3.96	4.58	6.53	6.79	6.43	5.80
P/TBV Ratio	4.16	4.82	6.90	7.23	6.76	6.15
P/FCF Ratio	17.77	20.57	41.66	50.42	48.83	55.02
P/OCF Ratio	11.70	13.55	27.48	29.55	25.45	28.72
PEG Ratio	1.22	1.32	2.22	2.25	1.92	2.39
EV/Sales Ratio	5.24	6.15	8.57	9.38	8.48	7.11
EV/EBITDA Ratio	15.75	18.52	23.78	25.61	23.49	20.16
EV/EBIT Ratio	20.86	24.45	30.63	32.57	29.23	25.15
EV/FCF Ratio	18.24	21.38	43.18	52.84	51.08	57.95
Debt / Equity Ratio	0.21	0.21	0.23	0.29	0.31	0.33
Debt / EBITDA Ratio	0.79	0.79	0.81	1.04	1.07	1.08
Debt / FCF Ratio	0.92	0.92	1.47	2.15	2.33	3.12
Asset Turnover	0.56	0.56	0.56	0.54	0.56	0.59
Inventory Turnover	7.52	7.52	7.04	6.40	6.24	6.25
Quick Ratio	1.64	1.64	1.58	1.69	1.64	1.70
Current Ratio	1.99	1.99	1.95	2.05	2.06	2.17
Return on Equity (ROE)	18.75%	18.75%	21.17%	21.90%	24.03%	25.35%
Return on Assets (ROA)	8.72%	8.72%	9.82%	9.64%	10.09%	10.35%
Return on Capital (ROIC)	10.41%	10.41%	11.56%	11.21%	11.61%	12.09%
Return on Capital Employed (ROCE)	16.00%	16.00%	18.30%	17.30%	18.20%	18.70%
Earnings Yield	439.29%	3.79%	2.94%	2.87%	3.33%	3.83%
FCF Yield	562.86%	4.86%	2.40%	1.98%	2.05%	1.82%
Dividend Yield	272.10%	2.35%	1.59%	1.48%	1.65%	1.91%
Payout Ratio	5419.97%	54.20%	45.61%	45.89%	43.24%	37.87%
Total Shareholder Return	272.10%	2.35%	1.59%	1.48%	1.65%	1.91%

Updated Mar 11, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.